Repurposing antidepressants and phenothiazine antipsychotics as efflux pump inhibitors in cancer and infectious diseases

B Rácz, G Spengler - Antibiotics, 2023 - mdpi.com
Multidrug resistance (MDR) is a major obstacle in the therapy of infectious diseases and
cancer. One of the major mechanisms of MDR is the overexpression of efflux pumps (EPs) …

[HTML][HTML] The application of antidepressant drugs in cancer treatment

Y Zheng, X Chang, Y Huang, D He - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Antidepressants refer to psychotropic drugs which are used to treat mental illness with
prominent emotional depression symptoms. It was reported that antidepressants had …

[HTML][HTML] Fluoxetine inactivates STAT3/NF-κB signaling and promotes sensitivity to cisplatin in bladder cancer

CJ Yang, ZL Tan, JD Yang, FT Hsu… - Biomedicine & …, 2023 - Elsevier
Bladder cancer is known as one of the top ten most common cancer types worldwide and
can be majorly divided into muscles invasive bladder cancer (MIBC) and non-muscles …

Magnolol suppresses ERK/NF-κB signaling and triggers apoptosis through extrinsic/intrinsic pathways in osteosarcoma

CH Li, M Ku, K Lee, P Yueh, F Hsu, R Lin… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: Osteosarcoma is an aggressive primary malignant bone tumor that occurs
in childhood. Although the diagnostic and treatment options have been improved …

Antitumoral effects of tricyclic antidepressants: beyond neuropathic pain treatment

A Asensi-Cantó, MD López-Abellán… - Cancers, 2022 - mdpi.com
Simple Summary Tricyclic antidepressants (TCAs) are old and known therapeutic agents
whose good safety profile makes them good candidates for drug repurposing. As the …

The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events

S Timilsina, S Rajamanickam, A Rao, P Subbarayalu… - Cancer letters, 2022 - Elsevier
Aberrant activities of various cell cycle and DNA repair proteins promote cancer growth and
progression and render them resistant to therapies. Here, we demonstrate that the anti …

[HTML][HTML] Unveiling nature's potential weapon: Magnolol's role in combating bladder cancer by upregulating the miR-124 and inactivating PKC-δ/ERK axis

FT Hsu, WL Liu, SR Lee, LB Jeng, JH Chen - Phytomedicine, 2023 - Elsevier
Background Bladder cancer (BC) is a challenging disease to manage. Researchers have
been investigating the potential of magnolol, a compound derived from Magnolia officinalis …

Amentoflavone induces caspase‐dependent/− independent apoptosis and dysregulates cyclin‐dependent kinase‐mediated cell cycle in colorectal cancer in vitro and …

CH Lin, KH Lin, HJ Ku, KC Lee, SS Lin… - Environmental …, 2023 - Wiley Online Library
Colorectal cancer (CRC) is recognized as the third most common malignancy and the
second most deadly in highly developed countries. Although the treatment of CRC has …

Protein kinase C (PKC) isozymes as diagnostic and prognostic biomarkers and therapeutic targets for cancer

T Kawano, J Inokuchi, M Eto, M Murata, JH Kang - Cancers, 2022 - mdpi.com
Simple Summary Protein kinase C (PKC) isozymes play key roles in the proliferation,
differentiation, survival, migration, invasion, apoptosis, and anticancer drug resistance of …

Unlocking synergistic potential: Enhancing regorafenib efficacy in hepatocellular carcinoma through combination therapy with 18β-Glycyrrhetinic acid

JDI Yang, PF Yueh, TL Liao, YT Chen… - Anticancer …, 2023 - ar.iiarjournals.org
Background/Aim: Hepatocellular carcinoma (HCC) is a primary liver cancer with limited
treatment options and poor prognosis. Regorafenib, a multi-kinase inhibitor, has shown …